Unit 33: The Immune System — BIOLOGY FOR AP COURSES notes: By the end of this unit you should be able to compare innate and adaptive immunity, explain how antibodies recognize and neutralize threats, and describe how the immune system can fail or be misdirected.
⤢ Enlarge| Term | Meaning |
|---|---|
| Adaptive immunity | Immunity with memory that develops after exposure to an antigen, either from a pathogen or from a vaccination. |
| Affinity | The strength of attraction between an antibody binding site and an epitope, based on molecular complementarity. |
| Allergy | An immediate hypersensitivity in which antibodies trigger a reaction within minutes of exposure to a harmless antigen. |
| Antibody | A protein made by plasma cells after stimulation by an antigen; also called an immunoglobulin. |
| Antigen | A foreign, or non-self, protein that triggers the immune response. |
| Antigen-presenting cell (APC) | An immune cell that detects, engulfs and processes an antigen, then displays it on its surface to inform the adaptive response. |
| Autoantibody | An antibody that incorrectly marks the body’s own components as foreign and stimulates an immune response against them. |
| Autoimmune response | An inappropriate immune response directed at host cells or self antigens. |
| Autoimmunity | A type of hypersensitivity in which the immune system reacts to self antigens. |
| Avidity | The total binding strength of a multivalent antibody with its antigen, taking all of its binding sites together. |
| B cell | A lymphocyte that matures in the bone marrow and can differentiate into antibody-secreting plasma cells. |
| Basophil | A leukocyte that releases chemicals, usually involved in the inflammatory response. |
| Cell-mediated immune response | An adaptive immune response carried out by T cells. |
| Clonal selection | The activation of B cells that carry one specific B cell receptor variant, followed by a large increase in the number of those cells. |
| Complement system | An array of about 20 soluble innate proteins that enhance phagocytosis, damage pathogen membranes and recruit lymphocytes. |
| Cross reactivity | Binding of an antibody to an epitope on an antigen that is different from the one the antibody was made against. |
| Cytokine | A chemical messenger that regulates cell differentiation, proliferation, gene expression and cell movement during immune responses. |
| Cytotoxic T lymphocyte (CTL) | An adaptive immune cell that kills infected cells directly with perforin and granzymes and releases cytokines to strengthen the response. |
| Dendritic cell | An immune cell that processes antigen material and presents it on its surface to induce an immune response. |
| Effector cell | A lymphocyte that has differentiated into an active form, such as a B cell that became a plasma cell or a cytotoxic T lymphocyte. |
| Eosinophil | A leukocyte that responds to parasites and takes part in the allergic response. |
| Epitope | The small part of an antigen that is specifically recognized by antibodies, B cells and T cells; also called the antigenic determinant. |
| Granzyme | A protease that enters target cells through perforin and induces apoptosis; used by NK cells and killer T cells. |
| Helper T lymphocyte (TH) cell | An adaptive immune cell that binds antigen-presenting cells through MHC II and either stimulates B cells or secretes cytokines. |
| Host | An organism that is invaded by a pathogen or parasite. |
| Humoral immune response | An adaptive immune response controlled by activated B cells and the antibodies they produce. |
| Hypersensitivities | Harmful immune responses to harmless foreign particles or self antigens, including immediate, delayed and autoimmune types. |
| Immune tolerance | The acquired ability to prevent an unnecessary or harmful immune response to a harmless foreign body or to self antigens. |
| Immunodeficiency | A failure, insufficiency or delay at any level of the immune system, which may be acquired or inherited. |
| Inflammation | Localized redness, swelling, heat and pain that result from leukocytes and fluid moving through opened capillaries to an infection site. |
| Innate immunity | Immunity that occurs naturally because of genetic factors or physiology and is not induced by infection or vaccination. |
| Interferon | A cytokine that inhibits viral replication and modulates the immune response. |
| Lymph | Watery fluid that bathes tissues and organs, carries protective white blood cells and contains no red blood cells. |
| Lymphocyte | A leukocyte with a large nucleus and very little cytoplasm; B cells, T cells and NK cells are lymphocytes. |
| Macrophage | A large phagocytic cell that engulfs foreign particles and pathogens. |
| Major histocompatibility class (MHC) I/II molecule | A cell surface protein that shows the immune system whether a cell is healthy or infected by displaying fragments; class I is found on nearly all nucleated cells and class II mainly on antigen-presenting cells. |
| Mast cell | A leukocyte that releases inflammatory molecules, such as histamine, in response to large pathogens and allergens. |
| Memory cell | An antigen-specific B or T cell that does not become an effector cell during the first response but can do so immediately on re-exposure to the same pathogen. |
| Monocyte | A white blood cell that circulates in the blood and lymph and becomes a macrophage after it enters infected tissue. |
| Mucosa-associated lymphoid tissue (MALT) | Lymphatic tissue that combines with the epithelial tissue lining the mucosal surfaces of the body. |
| Natural killer (NK) cell | A lymphocyte that can kill cells infected with viruses or tumor cells. |
| Neutrophil | A phagocytic leukocyte that engulfs and digests pathogens. |
| Opsonization | A process that enhances phagocytosis by using proteins to tag a pathogen so that phagocytic cells can recognize it. |
| Passive immunity | Temporary protection against pathogens gained when antibodies are transferred from one individual to another. |
| Pathogen | An agent, usually a microorganism, that causes disease in the organisms it invades. |
| Pathogen-associated molecular pattern (PAMP) | A carbohydrate, polypeptide or nucleic acid signature expressed by viruses, bacteria and parasites that differs from molecules on host cells. |
| Pattern recognition receptor (PRR) | A molecule on macrophages and dendritic cells that binds pathogen signatures and promotes engulfment and destruction of the pathogen. |
| Perforin | A destructive protein that creates a pore in a target cell; used by NK cells and killer T cells. |
| Plasma cell | An immune cell that secretes antibodies and arises from B cells stimulated by antigens. |
| Regulatory T (Treg) cell | A specialized lymphocyte that suppresses local inflammation and the secretion of cytokines and antibodies, and is involved in immune tolerance. |
| T cell | A lymphocyte that matures in the thymus gland and is one of the main cells of the adaptive immune system. |